QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 26.60

+9.2%

Nov 24 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DeadHead who wrote (474)	3/6/1997 2:50:00 AM
From: Mike Relyea	of 1693

Gordon, Your comment, in your post #474, "Yes, but don't overlook their ability to take a blood sample and send it to the lab. This is the real competition QDEL and CMTR are up against" has no merit. With Quidel's CLIA waved One-Step H. pylori test it would not be cost effective for physicians to send a blood sample to a lab. The lab would just use Quidel's test or a similar serologic antibody test and charge for its service. Doctor's may send a biopsy or breath sample to a lab, but these tests are much, much more expensive and will not compete for the same point of care market as Quidel's H.pylori test. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next